On Invalid Date, Quince Therapeutics (NASDAQ: QNCX) reported Q3 2023 earnings per share (EPS) of -$0.15, up 31.82% year over year. Total Quince Therapeutics earnings for the quarter were -$5.35 million. In the same quarter last year, Quince Therapeutics's earnings per share (EPS) was -$0.22.
As of Q1 2024, Quince Therapeutics's earnings has grown year over year. Quince Therapeutics's earnings in the past year totalled -$28.03 million.
What is QNCX's earnings date?
Quince Therapeutics's earnings date is Invalid Date. Add QNCX to your watchlist to be reminded of QNCX's next earnings announcement.
What was QNCX's revenue last quarter?
On Invalid Date, Quince Therapeutics (NASDAQ: QNCX) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Quince Therapeutics's revenue was $0.00.
What was QNCX's revenue growth in the past year?
As of Q1 2024, Quince Therapeutics's revenue has grown null year over year. Quince Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.